Jim DuCharme

Prime Therapeutics

Drugs are expensive, and Jim DuCharme, the recently named president and CEO of prescription benefit manager Prime Therapeutics, says he’s on a mission to tame what he calls the “runaway freight train of rising drug costs.” Pharmacy costs are a big driver of that equation, and in August, DuCharme announced that St. Paul-based Prime, owned by the nation’s 14 Blue Cross Blue Shield health plans, had forged a strategic alliance with Walgreens in a bid to promote prescription-filling operating efficiencies. He has called for “strong and decisive action” to rein in drug costs, and 2017 will likely bring more initiatives from Prime.